|
WO2021021830A1
|
|
Antibodies to candida and uses thereof
|
|
WO2020252432A1
|
|
Spectrum-splitting concentrator photovoltaic module with direct fluid cooling, and associated methods
|
|
WO2020252431A1
|
|
Hybrid receiver for concentrated photovoltaic-thermal power systems, and associated methods
|
|
WO2020243558A1
|
|
Nanotubes in porous particles
|
|
WO2020227134A1
|
|
Method for treating opioid use disorder
|
|
WO2020215058A1
|
|
Systems and methods for sample positioning to facilitate microscopy
|
|
WO2020205654A1
|
|
Multivalent vaccines derived from klebsiella out membrane proteins
|
|
WO2020191115A1
|
|
Method of improving the in vivo survival of mesenchymal stem cells
|
|
WO2020159880A1
|
|
Crispr-based methods and novel compositions for treating vascular disorders
|
|
US2020138934A1
|
|
Methods and compositions for inducing an immune response to Pseudomonas aeruginosa pulmonary infections
|
|
US2019283329A1
|
|
Method and system for rapid and efficient three-dimensional printing
|
|
WO2019222070A1
|
|
Refractive-index sensor and method
|
|
WO2019217473A1
|
|
Mutant e. coli enterotoxins as anti-inflammatory agents
|
|
KR20200142028A
|
|
Burkholderia pseudomalei complex outer membrane endoplasmic reticulum as an adjuvant
|
|
EP3755368A1
|
|
Pharmaceutical composition for viral infections
|
|
US2019211063A1
|
|
Pore-forming peptides and uses thereof
|
|
WO2019113080A1
|
|
Cell systems using spheroids and methods of making and using the same
|
|
US2019078092A1
|
|
Preventing tumor development and metastasis
|
|
WO2019084343A1
|
|
Peptide compositions and methods of use thereof
|
|
US2020272910A1
|
|
Quantum annealing with oscillating fields
|
